How Peptide Testing Works: HPLC, Mass Spec, and What Lumen Labs Actually Measures

Peptide testing is straightforward in concept: take a sample, run it through analytical instrumentation, compare measured values against the labelled claim. The implementation involves several specific analytical methods, each answering a specific question about what the sample contains. This guide walks through the methodology Lumen Labs uses, with the same rigour as our international peers an established international peptide-testing laboratory (Czechia) and another international laboratory (USA), so Filipino consumers understand what the analytical chemistry actually measures and what conclusions can be drawn.

We cover the four core methods (HPLC, mass spectrometry, water content, endotoxin), explain what each measures and what its limitations are, address common questions about test interpretation, and walk through the reporting standards that should appear on every credible certificate of analysis.

For the COA reading guide, see how to read a COA. For the vendor-COA verification problem, see why vendor-supplied COAs cannot be trusted. For HPLC specifically, see what is HPLC and why it matters.

What the analytical question actually is

When a Filipino consumer submits a peptide vial to Lumen Labs, they typically want answers to several questions:

1. Is the labelled peptide actually present? The identity question.
2. At what concentration? The quantitation question.
3. At what purity? The purity question.
4. Is the product safe to inject? The contamination question (sterility, endotoxins, microbial loads).

Each question is answered by a different analytical method or combination. No single test answers all four. A complete peptide analysis runs multiple methods in parallel.

High-Performance Liquid Chromatography (HPLC)

HPLC is the workhorse of peptide analysis. It separates components in a sample by physical-chemical properties (polarity, hydrophobicity, charge), allowing the analyst to see what the sample actually contains as a series of separated peaks.

How HPLC works

A liquid sample is injected into a column packed with a stationary phase (typically a chemically modified silica). A liquid mobile phase flows through the column under high pressure. Different compounds in the sample interact with the stationary phase to different degrees, eluting at different times. A detector (typically UV absorbance) measures each compound as it exits the column, producing a chromatogram.

For peptide analysis, the typical HPLC method:

• Reverse-phase column (C18 or similar) with hydrophobic stationary phase.
• Gradient elution from polar (water + 0.1% trifluoroacetic acid) to less polar (acetonitrile + 0.1% TFA) over 15 to 60 minutes.
• UV detection typically at 214 nm (peptide bond absorbance) or specific wavelengths for tryptophan-containing peptides.
• Sample preparation including dissolution at known concentration in compatible solvent.

What HPLC measures

The HPLC chromatogram shows:

• Retention time of each peak: when each compound elutes from the column.
• Peak area of each compound: proportional to the amount in the sample.
• Number of peaks: indicates purity (one peak = one compound; multiple peaks = multiple compounds).

For peptide purity, the calculation is:

• Percent purity = (target peptide peak area) / (total peak area) × 100%

A peptide labelled as "98% pure" should show a single dominant peak comprising 98% of total peak area, with smaller peaks comprising the remaining 2%.

What HPLC does not measure directly

HPLC by itself does not confirm identity. A peak at a specific retention time could in principle be the target peptide or a different peptide with similar chromatographic behaviour. To confirm identity, HPLC results must be combined with mass spectrometry or with comparison against a reference standard.

HPLC does not measure absolute concentration directly without external calibration. Quantitation requires comparing the sample peak area to a standard curve generated from known concentrations of authentic reference material.

Common HPLC findings

For Filipino peptide samples:

• Pass: target peptide peak at expected retention time, comprising 95%+ of total peak area, no significant impurity peaks.
• Underdosed: target peptide peak present but at lower-than-expected concentration when calibrated against standard.
• Wrong peptide: peak at different retention time than expected; not the labelled compound.
• Mixed product: multiple peaks of similar magnitude indicating multiple compounds.
• Degraded: target peak plus multiple smaller peaks indicating degradation products.

Mass Spectrometry (LC-MS, MS/MS)

Mass spectrometry confirms compound identity by measuring molecular mass. Each peptide has a specific molecular weight (the sum of its constituent amino acid masses minus water molecules from peptide bond formation). MS measurement of the molecular ion confirms whether the sample contains the target peptide or something else.

How LC-MS works

LC-MS combines HPLC separation with MS detection:

1. Sample is separated by HPLC as described above.
2. Eluting compounds enter the mass spectrometer through an electrospray ionisation source.
3. Compounds are ionised (typically protonated, becoming positively charged).
4. Ions are accelerated through a mass analyser that separates ions by mass-to-charge ratio.
5. Detector measures ion abundance at each mass-to-charge ratio.

The output is a mass spectrum showing peaks at specific m/z values. For peptides, the molecular ion peak corresponds to the protonated peptide molecule.

What LC-MS measures

The LC-MS spectrum shows:

• Molecular mass of each compound in the sample.
• Distinguishes structurally similar compounds that might co-elute on HPLC.
• Identifies fragmentation patterns in MS/MS that confirm sequence.

For peptide identity confirmation:

• Tirzepatide: 4813.5 Da (4 charges typically observed at m/z ~1204).
• Semaglutide: 4113.6 Da (3 charges at m/z ~1372).
• Retatrutide: 4731.3 Da.
• Liraglutide: 3751.2 Da.
• GHK-Cu: 340.4 Da (copper-bound complex).
• BPC-157: 1419.5 Da.

The masses are distinct enough that LC-MS reliably distinguishes between different peptides. A vial labelled tirzepatide that produces a mass spectrum at 4113.6 Da contains semaglutide, not tirzepatide.

What MS does not directly measure

MS does not directly measure absolute concentration without calibration. Standards and reference materials are required for quantitative MS analysis.

MS may have difficulty with very large proteins (full-length recombinant somatropin requires different methodology) or very small molecules (sometimes requires alternative ionisation methods).

Water content (Karl Fischer titration)

Lyophilised (freeze-dried) peptides should have low residual water content, typically less than 5% by weight. Higher water content indicates incomplete lyophilisation, which can:

• Reduce stability and shelf life.
• Indicate poor manufacturing quality.
• Cause discrepancy between label-claimed mass and actual peptide mass.

Karl Fischer titration is the standard method for water content measurement. A small sample is dissolved in a methanol-based titrant, and the water content is determined coulometrically.

Why water content matters

A vial labelled "5 mg peptide" that contains:

• 4.7 mg peptide + 0.3 mg water: appropriate.
• 4.0 mg peptide + 1.0 mg water: substantially underdosed in actual peptide content.
• 3.0 mg peptide + 2.0 mg water: dramatically underdosed.

Water content testing catches a specific quality failure that HPLC and MS may miss because they typically express results as a percentage of total mass without distinguishing water from peptide.

Endotoxin testing (LAL)

Bacterial endotoxin (lipopolysaccharide from gram-negative bacterial cell walls) is a major cause of injection-site reactions, fever, and systemic inflammatory response. Endotoxin testing measures the amount of bacterial endotoxin in a sample.

How LAL works

The Limulus amoebocyte lysate (LAL) test uses an extract from horseshoe crab blood that clots in the presence of endotoxin. The clotting kinetics or chromogenic colour change is measured and compared to a standard curve.

USP <85> specifies endotoxin limits for parenteral products. The limit depends on the route of administration and the volume injected. Typical injectable peptide products should have endotoxin below 0.5 EU/mg (endotoxin units per milligram).

Why endotoxin matters

A peptide vial that passes HPLC purity and LC-MS identity tests may still cause severe injection-site reactions or systemic inflammatory responses if endotoxin levels are high. This is a sterility-related quality issue that the chemical-identity tests do not catch.

Filipino users with severe injection-site inflammation, abscess formation, or systemic post-injection reactions should consider endotoxin contamination as part of the differential.

Microbial limits testing (USP 61)

USP 61 specifies acceptable microbial loads for non-sterile pharmaceutical products. For injectable peptides, sterile manufacturing is required and any detectable microbial contamination is a failure.

The test:

• Sample is plated on growth media.
• Media is incubated under appropriate conditions for bacteria, yeast, and mould.
• Colonies are counted after specified incubation time.

For Filipino peptide samples sourced through grey-market channels with uncertain manufacturing sterility, microbial limits testing identifies vials that should not be injected regardless of peptide content.

What the complete analytical workflow looks like

A typical Lumen Labs analysis for a submitted peptide vial:

1. Sample receipt and accessioning. Vial logged with submission ID, photographed, and tracked.
2. Visual inspection. Vial appearance, label, packaging documented.
3. Sample preparation. Aliquot dissolved in appropriate solvent at known concentration.
4. HPLC analysis. Purity measurement at appropriate UV wavelength.
5. LC-MS analysis. Molecular mass measurement to confirm identity.
6. Quantitation. Calibration against authentic reference standard to determine actual concentration.
7. Optional water content (for lyophilised samples).
8. Optional endotoxin and microbial limits (for injectable use questions).
9. Data review and report generation. Methodology, results, uncertainty, conclusions.
10. Certificate of analysis issuance. Verification key included for authenticity confirmation.

Total turnaround typically 5 to 10 business days for the standard panel; longer if additional testing is required.

What good methodology looks like in a COA

A credible certificate of analysis includes:

• Sample identification: ID, photograph, label data.
• Methodology named: HPLC, LC-MS, with column, wavelength, gradient details.
• Reference standard used: name, source, lot number.
• Measured values: with appropriate uncertainty range.
• Comparison to label claim: explicit pass/fail or numerical deviation.
• Lab signature and authentication: lab identifier, date, verification key.

Lumen Labs COAs follow this template. Vendor-supplied COAs without these elements are difficult to verify; for the deep dive on the vendor-COA fraud problem, see why vendor-supplied COAs cannot be trusted.

Limitations of analytical chemistry

Analytical testing answers specific questions and has specific limitations:

• Measures the sample submitted, not the entire batch. Heterogeneity within a batch is not captured by single-vial testing.
• Measures the sample at the time of testing, not its history. A vial that tested correctly may degrade subsequently with poor storage.
• Does not measure clinical effect directly. Bioavailability, absorption, and individual response are downstream of the analytical question.
• Subject to method limits of detection and quantitation. Very low levels of contaminants below detection limits are not directly visible.

For most Filipino peptide quality questions, analytical chemistry provides the dominant useful information. The limitations are real but rarely change the practical conclusions.

Bottom line on peptide testing methodology

Peptide testing combines multiple analytical methods to answer specific questions about what a sample contains. HPLC measures purity. Mass spectrometry confirms identity. Water content catches lyophilisation failures. Endotoxin and microbial limits catch sterility issues.

Lumen Labs operates as the Philippine peer to an established international peptide-testing laboratory (Czechia) and another international laboratory (USA) on this methodology. The output is a certificate of analysis that converts label claim into measured data.

For Filipino consumers spending meaningful amounts on peptide products, the analytical question is solvable. The cost of one test is small relative to multiple months of injecting product whose actual content is unknown.

Disclaimer: Lumen Labs provides chemical analysis of submitted samples for harm-reduction and quality-verification purposes. We are not a substitute for medical care. Many peptides discussed in this article are not FDA Philippines registered for human use. Consult a qualified Philippine licensed physician before any peptide use.